Aldeyra Therapeutics Inc (ALDX)
4.87
+0.11
(+2.31%)
USD |
NASDAQ |
Nov 21, 14:17
Aldeyra Therapeutics Price: 4.87 for Nov. 21, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 20, 2024 | 4.89 | 5.01 | 4.695 | 4.76 | 603967.0 |
Nov 19, 2024 | 4.64 | 5.00 | 4.64 | 4.94 | 705819.0 |
Nov 18, 2024 | 4.90 | 5.12 | 4.32 | 4.70 | 2.085M |
Nov 15, 2024 | 4.29 | 4.330 | 4.09 | 4.21 | 625242.0 |
Nov 14, 2024 | 4.42 | 4.51 | 4.16 | 4.27 | 686820.0 |
Nov 13, 2024 | 4.83 | 4.83 | 4.381 | 4.41 | 829936.0 |
Nov 12, 2024 | 5.42 | 5.42 | 4.57 | 4.755 | 795552.0 |
Nov 11, 2024 | 5.55 | 5.641 | 5.425 | 5.49 | 350648.0 |
Nov 08, 2024 | 5.37 | 5.575 | 5.25 | 5.52 | 337791.0 |
Nov 07, 2024 | 5.39 | 5.50 | 5.240 | 5.34 | 345980.0 |
Nov 06, 2024 | 5.54 | 5.74 | 5.24 | 5.40 | 574489.0 |
Nov 05, 2024 | 5.12 | 5.275 | 4.93 | 5.27 | 354996.0 |
Nov 04, 2024 | 5.34 | 5.39 | 5.09 | 5.18 | 329775.0 |
Nov 01, 2024 | 5.29 | 5.38 | 5.21 | 5.36 | 223657.0 |
Oct 31, 2024 | 5.31 | 5.34 | 5.16 | 5.26 | 335933.0 |
Oct 30, 2024 | 5.38 | 5.52 | 5.31 | 5.34 | 334443.0 |
Oct 29, 2024 | 5.67 | 5.715 | 5.37 | 5.42 | 508422.0 |
Oct 28, 2024 | 5.42 | 5.65 | 5.390 | 5.62 | 318694.0 |
Oct 25, 2024 | 5.40 | 5.525 | 5.27 | 5.325 | 387445.0 |
Oct 24, 2024 | 5.50 | 5.56 | 5.36 | 5.375 | 248653.0 |
Oct 23, 2024 | 5.87 | 6.075 | 5.44 | 5.50 | 601953.0 |
Oct 22, 2024 | 5.59 | 6.170 | 5.59 | 5.90 | 685901.0 |
Oct 21, 2024 | 5.63 | 5.70 | 5.48 | 5.53 | 408899.0 |
Oct 18, 2024 | 5.59 | 5.82 | 5.55 | 5.70 | 324135.0 |
Oct 17, 2024 | 5.60 | 5.70 | 5.49 | 5.55 | 224872.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.47
Minimum
Oct 27 2023
14.85
Maximum
Apr 27 2021
6.299
Average
5.94
Median
Oct 10 2023
Price Benchmarks
AbbVie Inc | 171.98 |
NovaBay Pharmaceuticals Inc | 0.70 |
Palatin Technologies Inc | 0.9146 |
iBio Inc | 2.39 |
Theriva Biologics Inc | 1.24 |
Price Related Metrics
Price to Book Value | 3.408 |
Earnings Yield | -15.40% |
Market Cap | 290.01M |